PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) Catches a Break
Yesterday PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) managed to log a sizable reversal session, after a predominantly red streak. The ticker shifted nearly 4.3 million shares and closed over 7% up, at $0.16 per share. The...